Abstract: This is a cross-sectional study, conducted from May to November/2014, in a dermatology reference unit, through review of medical records and interviews. In a sample of 49 patients with brachioradial pruritus, we observed higher prevalence of Caucasian (81.6%) and women (73.5 %), with a mean age of 56.1 years. Pruritus occurred in the topography of brachioradialis muscle in 87.8% of cases; 59.2% of the sample reported worsening of pruritus with sun exposure; the mean intensity of this symptom before treatment was 8.63. Therapy effectiveness was described as "very good/good" in 79.2% of cases, and for 55.3% relapses were categorized as "uncommon".
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The brachioradial pruritus (BRP) is an uncommon neurodermatitis, of uncertain etiology. 1, 2, 3 This condition is polymorphic, with itching, burning, stinging, or tingling sensations, particularly in the topography of the brachioradialis muscle (BRm), unilaterally or bilaterally. 4 ,5,6 Occasionally, it extends to the upper arms, shoulders, back, and cervical region or upper thorax. 4 The insidious clinical course, late diagnosis and poor or absent response to antihistamines and corticosteroids are associated with a significant impairment in the quality of life. 1, 4 Most publications involving BRP are case reports or case series 4, 5, 6 and there is no standardization in the assessment of disease severity, impact and activity that allows The Ice-Pack signal was positive in 46.9% patients, of whom 43.5% reported "good reduction" of itching with local ice application. 7 Anatomical changes in cervical thoracic spine were investigated by X-ray: reduction of the intervertebral spaces was found in 61.2%, and C6-C7 topography was the most affected (69.4%). Monotherapy was used in 59.2% of cases. Traditional tricyclic antidepressants (TCAs; amitriptyline, for example) were used in 33.3% of patients; doxepin (dibenzoxepin derivative TCA) in 22.8%, followed by antipsychotics (18.1%) and anticonvulsants (10.2%). The effectiveness of treatment was considered "very good"
and "good" in 79.2% of cases; 12.5% of the patients did not observe changes in symptoms (Tables 1 and 2 ).
The follow-up time ranged from 8 to 60 months, with a median of 35 months. In this period, recurrences were considered "uncommon" by 55.3% of patients, "frequent" by 29.8% and "very common" by 2.1%. Among the patients, 12.8% remained without pruritus during follow-up.
BRP is a peculiar medical condition diagnosed with increasing frequency in Dermatology. Most studies described a higher prevalence of the disease in women, 4, 8 with mean ages greater than 50 years. 3, 4, 6 Considering that BRP can be a harrowing morbid con- Mean follow-up in this study was higher than that described in previous series. 5, 6 TCAs, antipsychotics and anticonvulsants are central modulators of pruritus. 9 This study suggests that these drugs may be effective in BRP, reducing symptoms, as well as recurrences. This survey has limitations related to the study design, the sample size and selection method. New studies should assess the validity and psychometric properties of measures of disease activity or response to treatment in BRP.q 
